BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 23, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BVX-M001: Phase II start

In October, BiondVax will begin a double-blind, Israeli Phase II trial to evaluate 500 µg adjuvanted Multimeric-001 injection vs. adjuvanted and non-adjuvanted placebo solution in 160 volunteers....

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >